428
A. M. S. El-Sharief, R. Ketcham, M. Ries, E. Schaumann, and G. Adiwidjaja
Vol 47
2-(1,2-Dimethyl-5-mercaptoimidazol-4-yl)amino-2-imino-N-
methyl-thioacetamide (8B) and bis[4-(imino-(N-methylthiocarba-
moyl)methyl)amino-1,2-dimethylimidazol-5-yl] disulfide (9). An
ethereal (20 mL) solution of 3a (3.24 g, 20 mmol), 6a (3.66 g,
20 mmol), and triethylamine (three drops) was stirred at 20ꢁC
for 30 min and then allowed to stand for 16 h. The solid prod-
uct was extracted several times with cold ethanol. The remain-
ing solid was recrystallized from boiling ethanol to give 8 as
yellow crystals (9.73 g, 20%); m.p. 173–175ꢁC. IR (KBr): v~ ¼
nitrogen in the thioamide moiety in 3 attacks the elec-
trophilic imine carbon of 5, whereas the nitrile function
provides the opportunity for subsequent cyclization to
give imidazolidines 6. However, among the possible tau-
tomers 6B is apparently preferred and can be isolated
for R2 ¼ methyl whereas compounds with R2 ¼ aryl
tend to add a second equivalent of imine 5 and easily
undergo oxidative dimerization. The ready oxidation of
imidazole-4-thiols had been seen before in similar exam-
ples [5,8]. Unfortunately, the disulfide form of L-ovo-
thiol A (1a) is biologically inactive [6] and this may
also be anticipated for the disulfides of this work.
1
3150–3300, 2930–2970, 1450, 1130 cmꢀ1. H NMR: d ¼ 2.50
(s, 3 H, CCH3), 2.90 (d, J ¼ 6 Hz, 3 H, NHCH3, collapses to
s with D2O), 3.56 (s, 3 H, CH3N), 7.63, 9.33, 10.40 (each s,
3H, broad NH, exchanges with D2O). Concentration of the
ethanolic extract from earlier gave 9 as reddish crystals (145
mg, 30%); m.p. 195–197ꢁC. IR (KBr): v~ ¼ 3350–3230 (broad,
1
NH), 2910–2980, 1470, 1150 cmꢀ1. H NMR: d ¼ 2.29 (s, 6
EXPERIMENTAL
H, CH3C), 3.21 (s, 6 H, CH3NH), 3.3 (s, 6 H, CH3N), 7.47,
8.99, 9.88 (each broad, NH; exchanges with D2O).
C16H24N10S4. (484.7): calcd. C 39.65, H 4.99, N 28.90, S
26.46; found C 39.60, H 5.00, N 29.00, S 26.50.
General. NMR: Bruker WP 80–FT, AMX 400, or Varian
FT–80A; CDCl3 as solvent unless stated otherwise, with TMS
as internal standard; coupling constants J are given in Hz. IR:
Perkin–Elmer FTIR 1720 X or Pye-Unicam SP3-200 spectrom-
eters. Elemental analyses: Institut fu¨r Pharmazeutische Chemie,
TU Braunschweig.
N-Methylcyanothioformamide (3a) [9] and cyanothioforma-
nilide (3b) [19] were prepared as previously described, though
in the preparation of 3b we found use of THF as solvent ad-
vantageous. For the synthesis of imine 5a see ref. [17], for
benzaldimine (5b) see ref. [20]; imine 5c [21] was prepared
analogously.
Bis(4-benzylidenamino-1-methyl-2-phenyl-imidazole)-5,50-diyl
disulfide (11a). An ethereal solution (20 mL) of 3a (1.0 g, 10
mmol), 5b (1.05 g, 10 mmol), and triethylamine was stirred at
20ꢁC for 0.5–2 h to provide yellow crystals (750 mg, 51%),
m.p. 187–190ꢁC. IR (KBr): v~ ¼ 1605, 1573. 1H NMR: d ¼
3.85 (s, 3 H, CH3), 7.2–7.78 (m, 10 H, Ph, CH), 8.99 (s, 1 H,
PhCH¼¼N). 13C NMR: d ¼ 158.6 (N¼¼CH), 155.7 (C-2), 149.8
(C-4), 136.3, 130.9, 128.9, 128.7, 128.6, 128.4, 128.2 (Ar),
116.4 (C-5), 32.5 (NCH3). MS: m/z (%) ¼ 585 (48) [M þ H],
481 (58), 437 (59), 393 (92), 349 (100). C34H28N6S2 (584.8):
calcd. for C 69.83, H 4.83, N 14.37, S 10.97; found C 69.13,
H 4.96, N 14.51, S. 10.65.
5-Amino-2,3-dimethyl-5-imidazoline-4-thione (6a). An ethe-
real (20 mL) solution of 3a (2.38 g, 20 mmol), 5a (3.66 g, 20
mmol), and triethylamine (three drops) was stirred for 30 min at
20ꢁC to give 6a as reddish–brown crystals (745 mg, 26%); m.p.
137ꢁC (dec.). IR (KBr): v~ ¼ 3370, 3180, 2950, 1470, 1140
Bis(4-benzylidenamino-1,2-diphenyl-imidazole)-5,50-diyl di-
sulfide (11b). An ethereal solution (20 mL) of 3a (1.62 g, 10
mmol), benzaldimine 5b (2.10 g, 20 mmol), and triethylamine
(three drops) was stirred for 30 min and allowed to stand over-
night. The yellow crystals were collected and recrystallized
from dichloromethane/methanol; yield 1.60 g (45%). m.p.
195ꢁC (dec.). Repeated crystallization afforded a product with
m.p. 207ꢁC (dec.). IR (KBr): v~ ¼ 1605, 1573, 1503, 1316
1
cmꢀ1. H NMR: d ¼ 1.44 (d, J ¼ 6.4, 3 H, CCH3), 3.36 (s, 3
H, CH3N), 5.13 (q, J ¼ 6.4, 1 H, CH), 5.58 (broad, 2 H, NH).
13C NMR: d ¼ 181.96 (C¼¼S), 159.37 (N¼¼C), 84.64 (CAMe),
32.28 (NAMe), 18.80 (Me). MS: m/z (%) ¼ 143 (100) [M], 128
(23) [MACH3], 74 (28), 69 (31). HRMS for (C5H9N3S þ H):
calcd 144.0595, found 144.0601.
cmꢀ1
.
1H NMR: d ¼ 6.96–7.48 (m, 13H), 9.11 (s, 1 H,
PhCH¼¼N). 13C NMR: d ¼ 159.3 (N¼¼CH), 155.7 (C-4), 148.6
(C-2), 136.62, 136.41, 129.52 (Ar), 130.94, 129.07, 128.90,
128.58, 128.48, 128.43, 127.88 (ArH), 119.0 (C-5). MS: m/z
(%) ¼ 709 (100) [M þ H], 337 (18), 289 (9), 161 (19), 105
(8). C44H32N6S2 (708.9): calcd C 74.55, H 4.55, N 11.86; S
9.05 found C 74.19; H 4.69; N 11.82; S 8.82.
5-Amino-2-methyl-3-phenyl-5-imidazoline-4-thione (6b). An
ethereal (25 mL) solution of 3b (1.62 g, 10 mmol), 5a (1.83 g,
10 mmol), and triethylamine (three drops) was stirred for 15
min and then diluted with hexane. The gummy residue was
extracted several times with hexane. These extracts were com-
bined with the ether-hexane solution. Removal of the solvents
under reduced pressure gave 6b as reddish brown crystals (308
mg, 15%); m.p. 125–127ꢁC. IR (KBr): v~ ¼ 3350, 3270, 2950,
Bis[4-(4-methoxybenzylidenamino)-1-methyl-2-(4-methoxy-
phenyl)-imidazole]-5,50-diyl disulfide (11c). Prepared by the
procedure described for 11 using 5c in place of 5b. Yield
55%, m.p. 155ꢁC. IR (KBr): v~ ¼ 1600, 1470, 1210 cmꢀ1. MS:
m/z (%) ¼ 352 (25) [M/2], 351 (100), 176 (14), 151 (48).
C38H36N6O4S2 (704.86) calcd. C 64.75 H 5.15 N 11.92, S
9.10; found C 64.70, H 5.50, N 12.00, S 9.10.
1470, 1130 cmꢀ1
.
1H NMR: d ¼ 1.33 (d, J ¼ 6.4 Hz, 3 H,
CH3), 5.78–5.60 (q, J ¼ 6.4, 1 H, CH and broad, 2 H, NH2,
exchangeable with D2O), 7.48 (m, 5 H, ArH). 13C NMR: d ¼
181.80 (C¼¼S), 159.03 (N¼¼C), 129.49, 128.44, 125.01 (Ph),
85.47 (CAMe), 19.63 (Me). MS: m/z (%) ¼ 205 (68) [M], 204
(8), 190 (7), 135 (12), 70 (100). C10H11N3S (205.3); calcd C
58.51, H 5.40, N 20.47, S. 15.62; found C 58.31, H 5.52, N
20.10, S 15.23.
N-(1,2-Dimethyl-5-thioxo-3-imidazolin-4-yl)acetamide (13a). A
solution of 6a (100 mg, 0.7 mmol) in acetic anhydride (1.4
mL, 14.8 mmol) was allowed to stand for 16 h. Removal of
acetic anhydride under reduced pressure gave a gummy prod-
uct which was triturated with water to afford dark pink crys-
tals of 13a (36 mg, 28%); m.p. 107–109ꢁC. IR: v~ ¼ 3191,
5-Imino-1-methyl-3-phenyl-4-thioxoimidazolidin-2-one (7). The
compound had been prepared before [10,16]. IR (KBr): 1766
(C¼¼O), 1659 (C¼¼N) cmꢀ1
.
13C NMR (CH3): d ¼181.9
1
1686, 1666, 1537 cmꢀ1. H NMR: d ¼ 1.63 (d, J ¼ 5.6, 3 H,
(C¼¼S), 154.8 (C¼¼O), 154.2. (C¼¼NH), 132.5 (Ar), 129.4,
CH3CN2), 2.67 (s, 3 H, CH3CO), 3.39 (s, 3 H, CH3N), 5.51
129.3, 126.9 (ArH), 26.8 (NCH3).
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet